Skip to main content

Navigation group

Type at least 3 characters
1,204 articles

Articles

Original Research

Published on 15 Nov 2021

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

in Cardiovascular and Smooth Muscle Pharmacology

  • Celestino Sardu
  • Massimo Massetti
  • Nicola Testa
  • Luigi Di Martino
  • Gaetano Castellano
  • Fabrizio Turriziani
  • Ferdinando Carlo Sasso
  • Michele Torella
  • Marisa De Feo
  • Gaetano Santulli
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
Frontiers in Pharmacology
doi 10.3389/fphar.2021.777083
  • 5,093 views
  • 45 citations